Table 3.
Demographics and Clinical Characteristics of MDA5 Positive and Negative DM Patients
MDA5-positive (N = 11) | MDA5-negative (N = 149) | p-value | |
---|---|---|---|
N (%) | N (%) | ||
Demographics | |||
Gender | 0.94 | ||
Male | 3 (27.3) | 39 (26.2) | |
Female | 8 (72.7) | 110 (73.8) | |
Race | 0.24 | ||
Caucasian | 8 (72.7) | 124 (83.2) | |
African American | 2 (18.2) | 17 (11.4) | |
Asian | 0 (0) | 6 (4.0) | |
Other | 1 (9.1) | 2 (1.3) | |
Mean age at diagnosis, y | 41.4 | 44.9 | 0.48 |
Median disease duration, m | 24.5 | 26.3 | 0.9 |
Clinical Features | |||
Gottron’s Papules/Sign | 11(100) | 111 (75)† | 0.055 |
Heliotrope rash | 9 (81.8) | 71 (48.0)† | 0.03 |
Weakness | 6 (54.5) | 138 (93.2)† | <0.001 |
Fever | 5 (45.5) | 24 (16.4)¥ | 0.017 |
Inflammatory Arthropathy | 9 (81.8) | 39 (26.7)¥ | <0.001 |
Raynaud’s Phenomenon | 5 (45.5) | 44 (30.3)§ | 0.3 |
Mechanic’s Hands | 9 (81.8) | 28 (19.0)‡ | <0.001 |
Interstitial Lung Disease | 8 (72.7) | 17 (11.4) | <0.001 |
Calcinosis | 3 (27.3) | 18 (12.1) | 0.15 |
Clinical data was not available for every MDA5-negative patient. Where indicated, n is less than 149.
n = 148;
n= 147;
n = 146;
n = 145